AlzeCure Pharma AB (publ) (FRA:AC6)

Market Cap	75.52M +234.2%
Revenue (ttm)	n/a
Net Income	-5.40M
EPS	-0.05
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.5100
Previous Close	0.5280
Day's Range	0.5100 - 0.5100
52-Week Range	0.0830 - 0.7360
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857 and ACD680 that...

• Industry: Pharmaceutical Preparations
• Founded: 2012
• Employees: 10
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AC6

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 17, 2026

Data Sources Report a data error